Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us

  • Exchange: Hong Kong
  • Sector: Health Care
  • Industry: Medical Equipment & Devices
  • Sub-Industry: Life Science Equipment

Biosino Bio-Technology & Science Inc

+ Add to Watchlist

8247:HK

5.000 HKD 0.0000.00%

As of 04:01:00 ET on 05/28/2015.

Snapshot for Biosino Bio-Technology & Science Inc (8247)

Open: 4.990 Day's Range: 4.850 - 5.900 Volume: 1,295,000
Previous Close: 5.000 52wk Range: 2.390 - 5.900 1-Yr Rtn: +74.98%

Stock Chart for 8247

No chart data available.
  • 8247:HK 5.000
  • 1D
  • 1M
  • 1Y
5.000
Interactive 8247 Chart

Previous Close

No chart data available.
Interactive Chart
  • 1D
  • 1W
  • 1M
  • YTD
  • 1Y
  • 3Y
  • 5Y
Close:
Open:
High:
Low:
Volume:
Recently Viewed Symbols
Save as Watchlist
Saving as watchlist...

Key Statistics for 8247

Current P/E Ratio (ttm) 115.0619
Estimated P/E(-) -
Relative P/E vs. HSI 9.8856
Earnings Per Share (ttm) 0.0348
Est. EPS -
Est. PEG Ratio -
Market Cap (M HKD) 656.52
Shares Outstanding (M) 64.29
30 Day Average Volume 283,167
Price/Book (mrq) -
Price/Sale (ttm) 1.9846
Dividend Indicated Gross Yield 2.49%
Cash Dividend (CNY) 0.0900
Dividend Ex-Date 05/26/2015
5 Year Dividend Growth -0.20%
Next Earnings Announcement 08/14/2015
mrq = Most Recent Quarter; ttm = Trailing Twelve Months

Income Statement for 8247

  • Revenue
  • Net Income (M/CNY)
  • Profit Margin (%)

Company Profile & Key Executives for 8247

Biosino Bio-Technology & Science, Inc. is a biotechnology company. The Company develops, manufactures, and markets protein-based in-vitro diagnostic reagents and biochemical drugs. The Company's diagnostic reagents help diagnose cardiac, helatic, diabetes, inflammation/immunology, and pancreatic related diseases.

Wu LebinChairman/PresidentJiang HongyanChief Financial Officer
Wang JianqingVP:Production & Quality ControlGao JieVP:Enterprise Planning
More Company Profile & Key Executives for 8247

Quotes delayed, except where indicated otherwise. All prices in local currency. Time is ET.

Sponsored Link
Advertisement
Advertisement
Sponsored Links
Advertisements
sec ||= nil